ANR.AX
Healthcare BiotechnologyAnatara Lifesciences Ltd
A$0.01
+0.00 +0.00% today
Price History
Not enough data
Key Stats
Market Cap
2.85M
Avg Volume
55,238
52W High
A$0.02
52W Low
A$0.01
Div. Yield
0.0%
Valuation
Forward P/E
0.45
P/B Ratio
4.50
P/S Ratio
8.94
EV/EBITDA
-2.54
EV/Revenue
7.45
Margins
Gross Margin 11.9%
Operating Margin (299.8%)
Net Margin (293.1%)
EBITDA Margin (293.7%)
Growth & Returns
Revenue Growth (YoY)
(68.4%)
Return on Equity
(149.6%)
Return on Assets
(59.4%)
Liquidity & Leverage
Current Ratio
7.58
Quick Ratio
7.44
Total Cash
470,917
Total Debt
0
About
Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in Australia. The company's products include irritable bowel syndrome; and Detach for the treatment of diarrhea in piglets. It also develops anti-obesity project, an oral complementary medication to assist weight reduction and control. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.
anataralifesciences.com